Related Experiment Video
Updated: Jul 5, 2026

Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus
Milan Flekac1, Jan Skrha, Jirina Hilgertova
13rd Dept, of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. milan.flekac@seznam.cz
Background:
Reactive oxygen species generated by hyperglycaemia modify structure and function of lipids, proteins and other molecules taking part in chronic vascular changes in diabetes mellitus (DM). Low activity of scavenger enzymes has been observed in patients with DM. Protective role of scavenger enzymes may be deteriorated by oxidative stress. This study was undertaken to investigate the association between gene polymorphisms of selected antioxidant enzymes and vascular complications of DM.
Results:
Significant differences in allele and genotype distribution among T1DM, T2DM and control persons were found in SOD1 and SOD2 genes but not in CAT gene (p < 0,01). Serum SOD activity was significantly decreased in T1DM and T2DM subjects compared to the control subjects (p < 0,05). SOD1 and SOD2 polymorphisms may affect SOD activity. Serum SOD activity was higher in CC than in TT genotype of SOD2 gene (p < 0,05) and higher in AA than in CC genotype of SOD1 gene (p < 0,05). Better diabetes control was found in patients with CC than with TT genotype of SOD2 gene. Significantly different allele and genotype frequencies of SOD2 gene polymorphism were found among diabetic patients with macroangiopathy and those without it. No difference was associated with microangiopathy in all studied genes.
Conclusion:
The results of our study demonstrate that oxidative stress in DM can be accelerated not only due to increased production of ROS caused by hyperglycaemia but also by reduced ability of antioxidant defense system caused at least partly by SNPs of some scavenger enzymes.
Insights
Genetic variations in antioxidant enzymes like SOD1 and SOD2 are linked to vascular complications in diabetes mellitus (DM). Lower enzyme activity and specific gene polymorphisms correlate with poorer diabetes control and increased risk of macroangiopathy.
Area of Science:
- Biochemistry
- Genetics
- Endocrinology
Background:
- Hyperglycemia in diabetes mellitus (DM) elevates reactive oxygen species (ROS), damaging vascular tissues.
- Reduced activity of scavenger enzymes is common in DM patients, potentially impairing antioxidant defenses.
- Oxidative stress exacerbates the protective role of scavenger enzymes.
Purpose of the Study:
- Investigate associations between gene polymorphisms of antioxidant enzymes and vascular complications in DM.
- Determine the impact of genetic variations on scavenger enzyme activity and diabetes control.
Main Methods:
- Genotyping of selected antioxidant enzyme genes (SOD1, SOD2, CAT).
- Measurement of serum superoxide dismutase (SOD) activity.
- Comparison of allele and genotype frequencies between diabetic patients (T1DM, T2DM) and controls.
- Analysis of associations with vascular complications (macroangiopathy, microangiopathy) and diabetes control.
Main Results:
- Significant differences in SOD1 and SOD2 allele/genotype distributions were found between diabetic and control groups (p < 0.01).
- Serum SOD activity was significantly lower in T1DM and T2DM patients (p < 0.05).
- SOD1 and SOD2 polymorphisms influenced SOD activity; specific genotypes (SOD1-AA, SOD2-CC) showed higher activity and better diabetes control.
- SOD2 gene polymorphism frequencies differed between diabetic patients with and without macroangiopathy.
Conclusions:
- Oxidative stress in DM is accelerated by increased ROS production and a diminished antioxidant defense system, partly due to single nucleotide polymorphisms (SNPs) in scavenger enzymes.
- SOD1 and SOD2 gene polymorphisms are associated with altered SOD activity and may contribute to vascular complications in diabetes.
Related Concept Videos
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
